The relationship between cardiac hemodynamics and exercise tolerance in cystic fibrosis.

Heart Lung

School of Kinesiology, University of Minnesota, Cooke Hall, 1900 University Ave. SE. Minneapolis, MN 55455, USA; College of Pharmacy, University of Arizona, 1295 N Martin Ave., Tucson, AZ 85721, USA.

Published: May 2017


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Individuals with cystic fibrosis (CF) have reduced pulmonary function and exercise tolerance. Additionally, these individuals may develop abnormal cardiac function. The implications of abnormal cardiac function on exercise tolerance are unclear in CF.

Objective: Study relationships between exercise cardiac hemodynamics and exercise tolerance in CF.

Methods: 17 CF and 25 controls participated in cardiopulmonary exercise testing to measure exercise duration and peak workload (PW). Cardiac index (QI) was measured using acetylene rebreathe and oxygen uptake (VO2) breath-by-breath. Forced expiratory volume in 1-second (FEV1) was performed at rest.

Results: Peak QI was 6.7 ± 0.5 vs. 9.1 ± 0.3 mL/min/m(2), CF vs. controls, respectively (P < 0.05). Linear regressions between QI (R(2) = 0.63 and 0.51) and exercise duration or PW were stronger than VO2 (R(2) = 0.35 and 0.37) or FEV1 (R(2) = 0.34 and 0.36) in CF, respectively (P < 0.05).

Conclusion: These data are clinically relevant suggesting attenuated cardiac function in addition to low airway function relate to exercise tolerance in CF.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860124PMC
http://dx.doi.org/10.1016/j.hrtlng.2016.03.001DOI Listing

Publication Analysis

Top Keywords

exercise tolerance
16
cardiac hemodynamics
8
hemodynamics exercise
8
cystic fibrosis
8
function exercise
8
abnormal cardiac
8
cardiac function
8
exercise
7
relationship cardiac
4
tolerance
4

Similar Publications

Effects of metabolic syndrome and its components on pulmonary function and functional capacity in children and adolescents with obesity.

Eur J Pediatr

September 2025

Division of Pulmonology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok Noi, Bangkok, 10700, Thailand.

Unlabelled: Obesity is a pervasive global health issue frequently associated with metabolic syndrome (MetS). Limited data exist regarding the impact of MetS and its individual components on pulmonary function in obese pediatric populations. This study investigated the relationship between MetS and lung function, and further identified specific MetS components that adversely affect pulmonary outcomes.

View Article and Find Full Text PDF

Background: Balloon pulmonary angioplasty (BPA) improves haemodynamics in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Previous studies on BPA have set the treatment objective to achieve a mean pulmonary arterial pressure (mPAP) of <30 mm Hg. However, the clinical impact of mPAP after BPA remains unclear.

View Article and Find Full Text PDF

Background: Increasing physical activity (PA) levels among people with disabilities requires innovative and accessible interventions. Telecoaching (TC) represents an innovative training approach that uses technological and digital tools, including computers, mobile devices, video tutorials, and training manuals, to remotely manage and deliver training programs. This study aimed to evaluate the safety, feasibility, and effectiveness of the TC across various functional limitations and health conditions, providing practical insights into its applications for promoting PA in various populations.

View Article and Find Full Text PDF

Introduction: Pulmonary hypertension is a pathophysiological disorder with poor prognosis. Exercise intolerance and lower physical activity levels are common features of pulmonary hypertension and affect patients' quality of life. Exercise training effectively improves clinical outcomes in this population, but access to rehabilitation centres is often limited.

View Article and Find Full Text PDF

Endocrine therapies for breast cancer (BC) (i.e., selective estrogen receptor modulators (SERMs) or aromatase inhibitors (AI)) lower the risk for cancer recurrence but are linked to an increased risk of type 2 diabetes (T2D).

View Article and Find Full Text PDF